RATIOS
Bliss GVS Pharma Ltd.
BSE
Jun 04
133.25
+0.25 (+ 0.19%)
Volume
24547
Prev. Close
133.00
Open Price
133.30
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 04
132.96
-0.20 ( -0.15%)
Volume
204355
Prev. Close
133.16
Open Price
133.80
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Ratio Analysis
for the last 5 years.
ISIN No
|
INE416D01022
|
Market Cap. ( ₹ in Cr. )
|
1401.00
|
P/BV
|
1.39
|
Book Value ( ₹ )
|
95.85
|
BSE Code
|
506197
|
52 Week High/Low ( ₹ )
|
186/92
|
FV/ML
|
1/1
|
P/E(X)
|
16.62
|
NSE Code
|
BLISSGVSEQ
|
Book Closure
|
25/07/2024
|
EPS ( ₹ )
|
8.00
|
Div Yield (%)
|
0.38
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 6.56 | 4.85 | 8.23 | 8.97 | 6.54 |
Diluted EPS (Rs.) | 6.50 | 4.77 | 8.10 | 8.81 | 6.40 |
Cash EPS (Rs.) | 9.11 | 7.08 | 9.66 | 10.27 | 7.88 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 100.47 | 94.42 | 89.96 | 82.12 | 73.26 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 100.47 | 94.42 | 89.96 | 82.12 | 73.26 |
Dividend / Share (Rs.) | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 |
Revenue From Operations / Share (Rs.) | 63.32 | 57.83 | 57.45 | 61.38 | 45.13 |
PBDIT / Share (Rs.) | 12.13 | 13.44 | 13.53 | 13.68 | 10.58 |
PBIT / Share (Rs.) | 9.56 | 11.19 | 12.07 | 12.34 | 9.25 |
PBT / Share (Rs.) | 8.94 | 6.71 | 11.11 | 12.19 | 8.84 |
Net Profit / Share (Rs.) | 6.55 | 4.84 | 8.21 | 8.94 | 6.54 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 19.15 | 23.23 | 23.55 | 22.28 | 23.44 |
PBIT Margin (%) | 15.10 | 19.34 | 21.01 | 20.11 | 20.48 |
PBT Margin (%) | 14.11 | 11.60 | 19.33 | 19.86 | 19.58 |
Net Profit Margin (%) | 10.33 | 8.36 | 14.28 | 14.56 | 14.50 |
Return on Networth / Equity (%) | 6.51 | 5.12 | 9.12 | 10.88 | 8.93 |
Return on Capital Employeed (%) | 9.20 | 11.31 | 12.74 | 14.42 | 11.92 |
Return On Assets (%) | 5.65 | 4.39 | 7.50 | 8.58 | 7.13 |
Long Term Debt / Equity (X) | 0.01 | 0.03 | 0.04 | 0.02 | 0.04 |
Total Debt / Equity (X) | 0.04 | 0.06 | 0.08 | 0.10 | 0.08 |
Asset Turnover Ratio (%) | 0.56 | 0.52 | 0.53 | 0.62 | 0.51 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 6.16 | 6.59 | 4.76 | 4.10 | 4.63 |
Quick Ratio (X) | 5.51 | 5.83 | 4.27 | 3.63 | 4.06 |
Inventory Turnover Ratio (X) | 3.96 | 3.74 | 3.58 | 4.04 | 2.99 |
Dividend Payout Ratio (NP) (%) | 0.00 | 10.28 | 6.07 | 5.58 | 7.64 |
Dividend Payout Ratio (CP) (%) | 0.00 | 7.02 | 5.15 | 4.85 | 6.34 |
Earning Retention Ratio (%) | 0.00 | 89.72 | 93.93 | 94.42 | 92.36 |
Cash Earning Retention Ratio (%) | 0.00 | 92.98 | 94.85 | 95.15 | 93.66 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 19.41 | 24.23 | 14.01 | 32.80 | 26.02 |
Interest Coverage Ratio (Post Tax) (%) | 11.48 | 16.80 | 9.50 | 21.79 | 17.09 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 1118.52 | 1075.66 | 734.56 | 733.93 | 966.41 |
EV / Net Operating Revenue (X) | 1.68 | 1.78 | 1.23 | 1.15 | 2.08 |
EV / EBITDA (X) | 8.75 | 7.65 | 5.21 | 5.17 | 8.85 |
MarketCap / Net Operating Revenue (X) | 1.86 | 1.95 | 1.24 | 1.25 | 2.19 |
Retention Ratios (%) | 0.00 | 89.71 | 93.92 | 94.41 | 92.35 |
Price / BV (X) | 1.17 | 1.19 | 0.79 | 0.93 | 1.35 |
Price / Net Operating Revenue (X) | 1.86 | 1.95 | 1.24 | 1.25 | 2.19 |
EarningsYield | 0.05 | 0.04 | 0.11 | 0.11 | 0.06 |